Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 TKL Appoints Global BD VP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

TKL Appoints Global BD VP

Bagshaw to lead strategic corporate and business development efforts

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Jeffrey Bagshaw has been appointed vice president of global business development for the Clinical Trials Division at TKL Research. Mr. Bagshaw will be responsible for leading international strategic corporate and business development efforts.
 
Mr. Bagshaw has more than 25 years of experience in the pharma, biopharma, medical device and applied genomic industries. Previously, he served as chief operating officer at Inclinix, Inc., where he was responsible for leading global operations, strategic partnership development and clinical research services. He also held various leadership roles at Inclinix in medical marketing and compliance, medical support services and business development.Additional experience includes leadership roles at Hoffmann-La Roche, Bristol-Myers Squibb and Exact Sciences.

“Jeff is a proven leader in business development and clinical operations,” said Dr. Robert Reardon, Ph.D., chief operating officer at TKL. “This unique combination gives him an exceptional ability to understand client needs and will help us tailor our offerings for rapid enrollment and high-quality clinical research.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics